The prognostic value of MGMT promoter status by pyrosequencing assay for glioblastoma patients’ survival: a meta-analysis

BACKGROUND: The prognostic value of the status of O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation measured by pyrosequencing assay (PSQ) among glioblastoma (GBM) patients was examined in meta-analysis. METHODS: Eligible studies that reported the association between the status of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Hailong, Wang, Shuying, Song, Chengwei, Zha, Yunhong, Li, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062843/
https://www.ncbi.nlm.nih.gov/pubmed/27733166
http://dx.doi.org/10.1186/s12957-016-1012-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062843/
https://www.ncbi.nlm.nih.gov/pubmed/27733166
http://dx.doi.org/10.1186/s12957-016-1012-4

Ejemplares similares